| |
| | Technology Ventures |
 | | The technology used by PNT is the result of three years of comprehensive research conducted at UNMC by Donald Miller, Ph.D., Jonathan Vennerstrom, Ph.D., Samuel Augustine, Pharm.D., Jon Wagner, Pharm.D. and Dennis Robinson, Ph.D. In 2002, PNT obtained exclusive, worldwide rights from UNeMed for the creatine ester technology. |
 | | PNT is currently developing clinical trials for the lead compound, creatine ethyl ester, with plans to bring the product to market in 2003. |
 | | PNT is based in Omaha, Nebraska and Samuel Augustine, Pharm D is President. |
| www.unmc.edu /unemed/BusinessDevelopment/techventures.htm (594 words) |
|